The continuing challenge of lower respiratory tract infections

Clinical Infectious Diseases

Volumn 34, Issue SUPPL. 1, 2002, Pages

  Moellering Jr , Robert C ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; COTRIMOXAZOLE; ERYTHROMYCIN; MACROLIDE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TETRACYCLINE;

ANTIBIOTIC THERAPY; HUMAN; LOWER RESPIRATORY TRACT INFECTION; MORBIDITY; MORTALITY; PRIORITY JOURNAL; SHORT SURVEY; STREPTOCOCCUS PNEUMONIAE;

CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); DRUG RESISTANCE, MICROBIAL; HUMANS; LUNG DISEASES; MENINGITIS, PNEUMOCOCCAL; PNEUMOCOCCAL INFECTIONS; PNEUMONIA, BACTERIAL; POPULATION SURVEILLANCE; RESPIRATORY TRACT INFECTIONS; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

EID: 0036498683     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/324524     Document Type: Short Survey

References (25)

1. The Thucydides syndrome: A new hypothesis for the cause of the plague of Athens
2. Factors behind virulence of 1918 influenza remain mysterious
3. Pneumococcal pneumonia: Diagnostic, epidemiologic, therapeutic, and prophylactic considerations
4. A resistant pneumococcus
5. Breakthrough bacteremia and meningitis during treatment with cephalosporins parenterally for pneumococcal pneumonia
6. Infection with Streptococcus pneumoniae moderately resistant to penicillin does not alter clinical outcome
7. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States
8. Pneumococcal macrolide resistance - Myth or reality?
9. Management of community-acquired pneumonia in the era of pneumococcal resistance
10. Macrolide resistance conferred by base substitutions in 23S rRNA
11. Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from eastern Europe and North America
12. Prevalence and characterization of the mechanisms of macrolide, lincosamide and streptogramin resistance in isolates of Streptococcus pneumoniae
13. Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong
14. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network
15. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones: A growing concern
16. Three levofloxacin treatment failures of pneumococcal respiratory tract infections
17. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia
18. Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in the United States during the 1999-2000 respiratory season: Results from the TRUST surveillance program
19. Appropriate use of antimicrobials for drug-resistant pneumonia focus on the significance of β-lactam-resistant S pneumoniae
20. Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia
21. Low dosage and long treatment duration of β-lactam. Risk factors for carriage of penicillin-resistant Streptococcus pneumoniae
22. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in Group A streptococci in Finland
23. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians
24. Pilot survey of primary care physicians in Massachusetts, 1998